Session # P618
Presenting Author: Meghan Towne, MS, CGC
Take home points:
- Trio exome sequencing, with both biological parents, demonstrated significantly higher diagnostic rates and lower variant uncertainty compared to other familial sample configurations (FSC). However, parental trios are not always possible.
- With 30% of cases in this cohort without a parental trio, there is a need to maximize the clinical utility of FSC.
- One approach is through standard evaluation of new evidence in the literature which was found to be the primary driver for proactive reclassifications across FSC.
- Authors: Meghan C. Towne; Melissa Holman; Andrew Giles; Brooklynn Gasser; Ginger J. Tsai; Brian Schoenfeld
- Conference:
ACMG 2024
- Date: Friday, Mar 15, 2024 10:30am - 12:00pm